Middle East And Africa Artesunate Market Size & Outlook, 2026-2034


Middle East And Africa Artesunate Market Insights

  • As per Reed Intelligence insights, Middle East And Africa’s Artesunate Market was valued at USD 62.4 Million in 2025 and is anticipated to expand to USD 112.26 Million by 2034.
  • From 2026 to 2034, the market is anticipated to expand at a CAGR of 6.77%.
  • Within Formulation, Injectable Artesunate accounted for the largest market size in 2025.
  • During the forecast period, Oral Artesunate is anticipated to remain the highest-growth segment within the Formulation category.

Other Key Findings


  • Middle East And Africa represented 12% of the global Artesunate Market size in 2025.
  • By 2034, United States is estimated to hold the largest position in the global market in terms of size.
  • Saudi Arabia is estimated to remain the fastest-growing market in Middle East and Africa, advancing to USD 17.03 Million by 2034.

Report Summary

Report Scope Details
Base Year for Study 2025
Study Period 2022-2034
Historical Period 2022-2024
Forecast Period 2026-2034
Market Size In 2025 USD 62.4 Million
Market Size In 2034 USD 112.26 Million
Largest segment Injectable Artesunate
Units Revenue in USD Million
CAGR 6.77% (2026-2034)
Segmnetation Covered
Middle East and Africa
  1. United Arab Emirates
  2. Saudi Arabia
  3. South Africa
  4. Egypt
  5. Nigeria
  6. Turkey
Formulation
  1. Injectable Artesunate
  2. Oral Artesunate
Application
  1. Severe Malaria Treatment
  2. Uncomplicated Malaria Treatment
End-Use
  1. Hospitals
  2. Clinics
  3. Retail Pharmacies
Distribution Channel
  1. Government Supply Programs
  2. Private Sector Distribution
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends